James G Bollinger Selected Research

Amyloid (Amyloid Fibrils)

1/2023	Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS.
1/2023	Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40.
12/2022	The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer's disease: a literature review.
7/2022	Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity.
1/2022	Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques.
10/2019	High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.
12/2016	Human Central Nervous System (CNS) ApoE Isoforms Are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared with Plasma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James G Bollinger Research Topics

Disease

9	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 12/2016
7	Asthma (Bronchial Asthma) 12/2016 - 04/2007
6	Inflammation (Inflammations) 12/2016 - 09/2006
4	Amyloidosis 01/2023 - 12/2016
4	Amyloid Plaque 01/2023 - 01/2022
2	Respiratory Hypersensitivity 12/2016 - 01/2013
2	Metaplasia 08/2011 - 04/2007
2	Neoplasms (Cancer) 10/2009 - 10/2003
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023
1	Sleep Deprivation 01/2023
1	Dementia (Dementias) 10/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2018
1	Mouth Neoplasms (Oral Cancer) 01/2016
1	Carcinogenesis 10/2009
1	Atherosclerosis 10/2009
1	Colonic Neoplasms (Colon Cancer) 10/2009
1	Myocardial Infarction 10/2008
1	Atherosclerotic Plaque (Atheroma) 10/2008
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2008
1	Hypercholesterolemia 10/2008
1	Stroke (Strokes) 10/2008
1	Fibrosis (Cirrhosis) 04/2007

Drug/Important Bio-Agent (IBA)

7	Amyloid (Amyloid Fibrils)IBA 01/2023 - 12/2016
7	Secretory Phospholipases A2IBA 12/2016 - 10/2003
4	Group X Phospholipases A2IBA 07/2013 - 04/2007
3	Apolipoproteins E (ApoE)IBA 01/2023 - 12/2016
3	Amyloid beta-PeptidesIBA 01/2023 - 07/2022
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
3	EicosanoidsIBA 12/2016 - 04/2007
3	AllergensIBA 01/2013 - 04/2007
3	CytokinesIBA 01/2013 - 04/2007
2	ApolipoproteinsIBA 01/2023 - 12/2016
2	Proteins (Proteins, Gene)FDA Link 12/2018 - 07/2013
2	OvalbuminIBA 12/2016 - 04/2007
2	Phospholipases (Phospholipase)IBA 12/2016 - 12/2010
2	EnzymesIBA 10/2009 - 09/2006
1	suvorexantIBA 01/2023
1	Orexin Receptor AntagonistsIBA 01/2023
1	Serum AlbuminIBA 01/2023
1	Peptides (Polypeptides)IBA 12/2022
1	Superoxide Dismutase-1IBA 12/2018
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2018
1	Messenger RNA (mRNA)IBA 12/2018
1	Antisense OligonucleotidesIBA 12/2018
1	Protein Isoforms (Isoforms)IBA 12/2016
1	AntigensIBA 12/2016
1	Phospholipase A2 ReceptorsIBA 12/2016
1	Group V Phospholipases A2IBA 01/2013
1	indoleIBA 08/2011
1	Methacholine Chloride (Methacholine)FDA Link 08/2011
1	cysteinyl-leukotrieneIBA 12/2010
1	LipidsIBA 10/2009
1	Mitogen-Activated Protein KinasesIBA 10/2009
1	Phospholipases A2 (Phospholipase A2)IBA 10/2009
1	darapladibIBA 10/2008
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 10/2008
1	Arachidonic Acid (Vitamin F)IBA 04/2007
1	Platelet Activating FactorIBA 09/2006

Therapy/Procedure

2	Therapeutics 07/2013 - 01/2013